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Abstract: Background: The ob-
jective assessment of the severity
of neonatal jaundice is Total Se-
rum Bilirubin (TSB) determina-
tion, which requires multiple
blood sampling. This has inherent
problems, including risks of anae-
mia and infection. Transcutaneous
Bilirubinometry (TcB) is a reli-
able, non-invasive alternative,
however there is paucity of data
on its performance in black pre-
term neonates.
Objectives: To evaluate the corre-
lation between transcutaneous
bilirubin (TcB) and total serum
bilirubin (TSB) among Nigerian
preterm neonates, and to deter-
mine the parameters affecting the
relationship.
Method: Jaundiced preterm neo-
nates delivered between 28 and 36
weeks of gestation admitted
at the Irrua Specialist Teaching
Hospital (ISTH), Nigeria were
recruited . The TSB
levels were determined by spec-
trophotometry while the corre-
sponding TcB levels were obtained
using Jaundice Meter (JM-103).
The neonates were stratified into
gestational age and birth weight
groups.
Results: A total of 189 paired TcB
and TSB levels were obtained
from 60 neonates. The
Mean (sd) TcB level of 11.4 (3.1)
mg/dl was significantly higher
than the mean TSB level of 10.2
(2.8)mg/dl (p= 0.028). The overall
correlation coefficient between
TcB and TSB was 0.98 and it was
not significantly affected by the
gestational age, birth weight and
bilirubin levels.
Conclusion: Transcutneous
bilirubin strongly correlates with
total serum bilirubin levels among
Nigerian preterm neonates, irre-
spective of gestational age, birth






Neonatal Jaundice (NNJ) is a major cause of neonatal
morbidity and mortality in developing
countries, including Nigeria1-3. Jaundice is more preva-
lent, more severe and associated with a higher risk of
bilirubin encephalopathy, and runs a more protracted
course in preterm than term neonates4-7.
Transcutaneous bilirubinometry, a non-invasive method
of assessment of severity of neonatal jaundice (NNJ) has
been extensively studied in term infants and shown to
significantly reduce the need for blood sampling and the
delay in intervention for NNJ in the Caucasians8-15. In
contrast, less has been done on the reliability of transcu-
taneous bilirubinometry in preterm neonates, particu-
larly in the Blacks. Transcutaneous bilirubinometry may
be more beneficial to the Blacks in the gross resource-
limited developing countries, particularly in Africa, be-
cause of the unfavourable conditions under which NNJ
is managed. These conditions include poor access to
healthcare facilities, erratic electricity, inadequate diag-
nostic and treatment facilities.
The Jaundice meter is portable and rechargeable.  More-
over, gestational age and skin pigmentation have been
speculated as potential limitations in the use of TcB16.
Previous studies among term neonates in Nigeria sug-
gested that skin pigmentation may not constitute a major
limitation to the use of transcutaneous bilirubinome-
ters1,17. There is however a dearth of data among preterm
neonates, especially among Blacks in which transcutane-
ous bilirubinometry may be of particular benefit. This
study set out to evaluate the correlation of the Jaundice
Meter (JM-103) with TSB in assessing the severity of
jaundice in Nigerian preterms and the factors affecting
its correlation.
Subjects and Method
The study was carried out at the Special Care Baby Unit
(SCBU) and Post Natal Ward (PNW) of Irrua Specialist
Teaching Hospital (ISTH), Edo State, Nigeria. Approval
was obtained from the Research and Ethics Committee
of the hospital while written informed consent was ob-
tained from the parents of the neonates involved. Sub-
jects were consecutive jaundiced preterm neonates be-
tween the gestational ages of 28 and 36 weeks. They
were recruited when the determination of serum
bilirubin levels was indicated based on clinical assess-
ment. Gestational age was assessed on admission using
the results of antenatal ultrasonography, Naegele’s rule
and clinical assessment using the new Ballard Score13.
Neonates who had undergone exchange blood transfu-
sion, and those whose gestational ages could not be
determined were excluded8,10. Neonates on phototherapy
who were otherwise eligible for recruitment were in-
cluded; an opaque plaster was applied to the site used
for Tc Breadings, to prevent the bleaching effect of pho-
totherapy on the skin18,19.
The TcB readings were carried out using the Jaundice
Meter-103 (JM-103). The JM-103 has been designed to
overcome the limitations of older versions of Jaundice
meters with respect to gestational age and skin pigmen-
tation10. The readings were taken over the forehead and
sternum8,10. Sampling for TSB was through venepunc-
ture immediately after TcB reading and analysis for TSB
was done at the Chemical Pathology Laboratory of the
hospital, using an SM23A spectrophotometer (Malloy
and Evelyn Method). Sampling was based on clinical
indication; an average of three samples was obtained
from each baby. The neonates were stratified into gesta-
tional age groups of 28-30 weeks, 31-33 weeks and 34-
36weeks and into birth weight groups less than 1000gm,
1000-1499gm, 1500-2499gm and2500gm and above.
Means of TcB readings and TSB levels were compared
using paired Student’s t-test while the correlation coeffi-
cient (r) between TcB readings and TSB levels was de-
termined using linear regression analysis. The differ-
ences in means of TcB readings and TSB levels among
the various categories of preterm neonates were com-
pared. P values less than <0.05 were considered to be
statistically significant.
Results
A total of 189 paired measurements of TcB readings and
TSB levels were obtained from 60 neonates, comprising
35 (58.3%) males and 25 (41.7%)females. They were all
born to Nigerian parents. The gestational age ranged
from 28 to 36with mean (SD) of 31.5 (2.7) weeks while
the birth weight ranged between 900 and 2600 with
mean (SD) of 1624 (583) gm. Twenty-eight (46.6%) of
the neonates were 28-30 weeks, and 16(26.7%) each in
the 31-33 weeks and 34-36 weeks categories.
Overall relationship between TSB and TcB levels
There was no statistically significant difference between
the mean of the sternal and forehead TcB readings (11.4
versus 11.3 mg/dl;95% CI of the difference = -0.51,
0.71, p= 0.746). The difference between the correlation
coefficients of sternal and forehead TcB readings with
TSB level was not statistically significant(0.98 versus
0.97, p = 0.76). The data obtained from sternal TcB
readings in relation to TSB levels are subsequently pre-
sented below.
The mean (sd) TcB level of 11.4 (3.1)mg/dl was signifi-
cantly higher than the mean TSB level of 10.2 (2.8)mg/
dl (p= 0.028).Of the 189 pairs, the TcB readings were
higher than the
TSB levels in 181 (95.8%), lower in four (2.1%) and
equal in four (2.1%) cases. The difference between TcB
and TSB was less than 1 mg/dl in 134 (70.9%), 1 - 1.9
mg/dl in 40 (21.2%) and 2 - 2.8 mg/dl in 15 (7.9%) of
the paired readings.
Fig 1 shows the linear regression of TcB readings on
TSB levels. There was a strong positive
relationship between TcB readings and TSB levels, with
correlation coefficient (r) of 0.98 and coefficient of de-
termination (R2) of 96 (p < 0.01). The linear relationship
between the two is described by the equation TSB =
TcB x 0.93.
Fig 1: Linear regres-
sion of TcB on TSB
for all the readings.
The effects of total serum bilirubin levels, gestational
age (GA) and birth weight on the relationship between
TcB readings and TSB levels.
Eleven neonates had TSB levels ≥15 mg/dl, the correla-
tion coefficient between TcB and TSB in
this TSB range was 0.78 while the correlation coeffi-
cient was 0.98 at TSB levels ≤ 14.9mg/dl. The differ-
ence clinically significant, although it did not attain sta-
tistically significance (p = 0.09) probably due to the
small number (n=11) in that range. The mean (SD) of
the difference between TcB readings and TSB levels of
1.16 (1.02) mg/dl at TSB levels ≥15 mg/dl was signifi-
cantly higher than that of 0.76 (0.62)mg/dl at lower TSB
levels ≤ 14.9mg/dl (p = 0.047).
The distribution of the means (SD) of TcB readings,
TSB levels and differences in TcB-TSB in
relation with GA are shown in Table 1. The means of
TSB readings and TcB levels increased significantly
with GA (p< 0.01). There was however no statistically
significant difference in the means of TcB readings and
TSB levels in any of the GA categories. The correlation
coefficients ‘r’ among the GA of groups 28-30 weeks,
31-33 weeks and 34-36 weeks were (r =0.97, 0.98 and
0.98, respectively). There was no statistically significant
difference in the correlation coefficient (r) within the
three GA groups.
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Table 1: Table showing the comparative statistics of TSB and
TcB for different gestational age categories.
Key: S.D = standard deviation; TSB = total serum bilirubin; TcB =
transcutaneous bilirubin; CI = confidence interval
Table 2 shows distributions of means (SD) values of
TcB and TSB, and the means (SD) of the differences
between TcB and TSB levels in relation to birth weight
categories. The Table shows the comparison between
the means of TcB and TSB for each of the birth weight
category. In each birth weight category, the mean of
TcB was higher than that of TSB, though the difference
was not statistically significant (p = 0.09 for < 1000gm,
p = 0.51 for 1000-1499gm, p = 0.25 for 1500-2499gm
and p = 0.42 for ≥ 2500gm. The means of both TSB and
TcB increased significantly with birth weight (p <0.01).
The correlation coefficients were r = 0.85 (p < 0.01); r =
0.98 (p < 0.01); r = 0.97 (p < 0.01); and r = 0.98 (p <
0.01) for the weight categories of <1000gm, 1000-
1499gm, 1500-2499gm and ≥2500gm respectively. The
weakest correlation coefficient between TcB and TSB
was thus in the <1000gm weight category. However
there was no statistically significant difference between
the correlation coefficients (r) between the various birth
weight categories (p = 0.08).
Table 2: Table showing the comparative statistics of TSB and
TcB for different birth weight categories.
Discussion
The present study revealed a strong correlation between
TcB readings and TSB levels in Black preterm neonates.
The correlation was not significantly affected by the
gestational age, Birth weight and, to a lesser extent, the
TSB levels within the range of TSB obtained. The
strength of the correlation was similar to that reported
by Maisels et al,8 Stillova et al20 and Ahmed et al21 in
studies which involved term and preterm Caucasian neo-
nates. The correlation coefficient was however higher
than that reported by Owa et al1, Slusher et al17 in Black
term neonates and Knupfer et al22 in a study involving
preterm Caucasian neonates. The greater correlation in




















28-30 88 8.1 (1.8) 8.5 (1.8) (-1.4, 0.6) -0.83  (0.41)
































ELBW 10 7.5 (1.0) 8.1 (0.7) (-1.3, 0.1) -1.77 (0.09)
VLBW 81 8.2 (1.9) 8.6 (2.0) (-1.6, 0.8) -0.66 (0.51)













P values < 0.01 < 0.01 < 0.01
previous studies on African term neonates1,17 and pre-
term Caucasian neonates may be due to the improved
sensitivity of the study instrument, the JM-103, which
was specifically designed to overcome the limitations of
the older versions of jaundice meters with respect to
gestational age and skin pigmentation.8,10
The tendency of higher TcB readings than TSB levels in
the present study is consistent with the findings of other
workers.8,20,23 This tendency for the TcB readings to be
higher than the TSB levels is not likely to result in major
errors in the management of preterm neonates with jaun-
dice. This is because at least one value of TSB is usually
obtained before instituting treatment.
Moreover, the practical implication is a probable slight
increase in the rate of interventions with phototherapy, if
only the TcB readings were used for the assessment of
the severity of the jaundice and in taking decision.
In agreement with the results of previous studies,8,20 the
correlation coefficient between TcB readings and TSB
levels in the present study was higher  with TcB meas-
urements taken over the sternum than that taken over the
forehead, although the difference was not statistically
significant. The difference has been attributed to the
probable bleaching effect of light on the forehead com-
pared to the relatively less exposed sternum,23 although
precautions were taken to minimize this effect. The ster-
num is thus the preferred site for TcB measurements.
The present study also revealed a lower correlation coef-
ficient at higher TSB values as had been previously
reported.8,11,17
The recommendation for the use of TcB as a screening
device is based on the assumption that serum and tissue
bilirubin levels are in constant equilibrium. This may
not be totally true. It is possible that at higher serum
bilirubin levels, the rate of equilibration between the
serum bilirubin and tissue bilirubin is reduced and more
bilirubin is retained in the tissues, including subcutane-
ous tissues. This may partly explain the increase in the
differences between the TcB readings and TSB
values at higher TSB levels. It is therefore important that
due caution is exercised not to use TcB readings alone in
decision-making at TcB readings above 15mg/dl. More
studies are required in this respect. The GA of the pre-
term neonates in the present study did not significantly
affect the relationship between TcB readings and TSB
levels. The difference in the correlation coefficients be-
tween the various GA categories of preterm neonates (r
= 0.97 versus r = 0.98) is too small to have any real
impact on the clinical judgment. This conclusion is in
agreement with the reports by Ahmed et al21 and
Schmidt et al24 that TcB is as reliable in neonates with
GA of 28 weeks as it is in late preterm neonates. Ex-
tremely preterm neonates have a more immature skin
with paucity of subcutaneous tissue, which can affect the
TcB readings. The use of transcutaneous bilirubinome-
try would appear more relevant in preterm neonates in
whom the risks of anaemia and infection from repeated
venepuncture are much higher.25-27
The difference between the means of TcB readings and
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TSB values is similar to that reported by Maisels et al.8
The maximum difference of 2.8mg/dl between TcB
readings and TSB values is comparable to the inter-
laboratory variations in TSB determination as reported
by Vreman et al28 and less than the difference reported
between a Bilirubinometer and Malloy-Evelyn method
of TSB determination by Owa.29 Therefore, the differ-
ences observed between TcB readings and TSB values
in the present study in the range of TSB of 5-18.7mg/dl
studied may be comparable to differences observed in
real clinical situations where different methods of TSB
determination are used.
Limitations
The limitations of this study include the small number of
ELBW neonates recruited and the very limited number
of bilirubin levels in the range of 15mg/dl and above.
Conclusion
The correlation between TcB and TSB levels in the
Nigerian preterm neonates is strong irrespective of the
gestational age, birth weight and TSB level.
It is recommended that transcutaneous bilirubinometry
be used routinely as a tool for the monitoring of severity
of NNJ in Blacks. This will reduce the delay in interven-
tion, minimize the problems of venepuncture and possi-
bly reduce the burden of ABE.
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